Medi Assist Q1 FY27 Results: Revenue Rises 24.1% to ₹236.5 Crore as AI Platform Monetisation Begins

What Happened ?

Medi Assist Healthcare Services reported Q1 FY27 operating revenue of ₹236.5 crore, representing 24.1% YoY growth. EBITDA increased 14.3% to ₹48.0 crore, although EBITDA margin declined to 20.3% from 22.0% a year earlier.

Reported PAT rose 21.9% YoY to ₹27.6 crore, while adjusted PAT increased 8.2% to ₹24.5 crore. The adjusted PAT excludes a one-time ₹3.1 crore derivative gain related to the acquisition of non-controlling interest in the Mayfair subsidiary. 

The quarter also highlighted three strategic developments: the Paramount integration reached its logical closure, the company’s AI technology platform entered early monetisation with seven insurer contracts, and Mayfair We Care transitioned into a structured international platform with majority ownership and a live Thailand deployment. 

key details

India TPA Franchise:

• Group revenue reached ₹166.0 crore, up 25.5% YoY.
• Group PUM increased 29.5% YoY to ₹8,454 crore.
• Group market share increased to 37.6%, up 440 bps YoY.
• Retention stood at 90.2%, reflecting the expected post-acquisition transition and portfolio rationalisation.
• TPA-model retail revenue increased 13.1% YoY to ₹23.4 crore.
• Government revenue increased 35.3% YoY to ₹28.5 crore.
• Government business covers approximately 31 crore members across 12 states and four Union Territories. 

Paramount Integration:

• The operational integration of Paramount is at its logical close.
• More than 95% of group claims and over 80% of retail claims have migrated to MAtrix, with full migration targeted for Q2 FY27.
• The company expects the near-term retention drag from the integration to normalise through FY27. 

Technology Platform:

Medi Assist has completed its planned approximately ₹24.5 crore AI platform investment over the last six quarters. Its technology stack, including MAven IDP, MAven Guard, MAven Digital Platform, MAtrix and MAgnum, is now generally available and has started generating incremental revenue. 

• Seven insurers have contracted across combinations of the MAven, MAtrix and MAgnum platforms.
• The first outcomes-based contract has been signed, linking compensation directly to measurable value delivered.
• Technology revenue increased 55.5% YoY to ₹7.8 crore.
• Technology revenue represented 3.3% of total revenue and the technology business is already margin accretive.
• More than 186,000 pre-authorisations were processed within five minutes.
• Raksha Prime delivered zero-wait discharge for 87,000+ members, up 29.9% YoY, across 6,000+ hospitals.
• MAtrix implementation at Star Health crossed 90%. 

International Platform:

Medi Assist increased its ownership in Mayfair We Care to 91.75% after Q1, converting the original seed investment into a majority-owned subsidiary and dedicated international vehicle. Nikhil Chopra, former Chief Business Officer of Medi Assist Group, has been appointed to lead the international business full-time. 

• The first Thailand technology deployment contract went live on 1 July 2026.
• Multiple corporates have been onboarded to the digital health benefits platform in Thailand.
• MAtrix claims integration is underway in the region.
• Mayfair’s Indian retail sign-ups provide visibility to more than 50% of travel premiums placed in India.
• International revenue stood at ₹10.1 crore, down 5.2% YoY, due to temporary industry-wide moderation in student, leisure and marine volumes. 

Financial Position:

• Free Cash: ₹245.5 crore as of June 30, 2026, compared with ₹260.5 crore in March 2026.
• Debt: Debt-free.
• Contract Liability: ₹337.4 crore versus ₹280.2 crore in March 2026.
• Net Worth: ₹884.1 crore versus ₹852.4 crore in March 2026.
• Management stated that technology and international growth initiatives are being funded through operating cash flows without external capital. 

Note:

• The company states that adjusted PAT excludes a one-time ₹3.1 crore derivative gain related to the acquisition of NCI in the Mayfair subsidiary.
• The source does not provide Q4 FY26 comparative earnings, so no QoQ performance has been inferred. 

Risk Analysis

Summary:

• Medi Assist delivered strong revenue growth, but EBITDA margin moderated YoY and the company remains in a transition phase as Paramount integration is completed and its technology and international businesses move toward larger-scale monetisation.

Key Risks:

• EBITDA margin declined 175 bps YoY to 20.3%.
• Near-term retention pressure from Paramount integration is expected to continue before normalising through FY27.
• International revenue declined 5.2% YoY in Q1 FY27.
• AI platform monetisation remains at an early stage despite seven insurer contracts.
• Management’s expected future EBITDA margin accretion from technology and international operations remains forward-looking.
• The company has issued a forward-looking disclaimer noting that future performance expectations involve risks and uncertainties. 

Worst Case:

• If Paramount integration takes longer to stabilise, technology monetisation scales slower than expected or international volumes remain subdued, the anticipated operating leverage and EBITDA margin expansion could be delayed.

Risk Level: Medium

Company Commentary

• The India TPA franchise remains Medi Assist’s core business engine.
• Paramount integration is at its logical closure.
• The AI platform has moved from investment to early monetisation, with seven contracts in place.
• Mayfair has transitioned into a structured international platform with dedicated leadership and a live Thailand deployment.
• Management expects technology licensing and international operations to become meaningful contributors to EBITDA margins over time.
• Both growth initiatives are being funded through operating cash flows.